Last updated: 20 August 2024 at 4:09pm EST

Cindy Jacobs Net Worth




The estimated Net Worth of Cindy Jacobs is at least $729 Thousand dollars as of 19 April 2024. Cindy Jacobs owns over 16,250 units of Achieve Life Sciences stock worth over $147,707 and over the last 7 years he sold ACHV stock worth over $0. In addition, he makes $580,857 as President at Achieve Life Sciences.

Cindy Jacobs ACHV stock SEC Form 4 insiders trading

Cindy has made over 9 trades of the Achieve Life Sciences stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 16,250 units of ACHV stock worth $69,550 on 19 April 2024.

The largest trade he's ever made was exercising 16,250 units of Achieve Life Sciences stock on 19 April 2024 worth over $69,550. On average, Cindy trades about 1,930 units every 99 days since 2017. As of 19 April 2024 he still owns at least 34,511 units of Achieve Life Sciences stock.

You can see the complete history of Cindy Jacobs stock trades at the bottom of the page.





Cindy Jacobs biography

Dr. Cindy Jacobs M.D. Ph.D. serves as President of the Company. Dr. Jacobs has served as our Executive Vice President and Chief Medical Officer since August 2008, and had been Executive Vice President and Chief Medical Officer of OncoGenex Technologies Inc. from September 2005 to August 2008. From 1999 to July 2005, Dr. Jacobs served as Chief Medical Officer and Senior Vice President, Clinical Development of Corixa Corporation. Prior to 1999, Dr. Jacobs held Vice President, Clinical Research positions at two other biopharmaceutical companies. As of January, 2018 Dr. Jacobs also serves on the board of directors of Renown Pharma Limited. Dr. Jacobs received her Ph.D. degree in Veterinary Pathology/Microbiology from Washington State University and an M.D. degree from the University of Washington Medical School.

What is the salary of Cindy Jacobs?

As the President of Achieve Life Sciences, the total compensation of Cindy Jacobs at Achieve Life Sciences is $580,857. There are 5 executives at Achieve Life Sciences getting paid more, with Richard Stewart having the highest compensation of $796,644.



How old is Cindy Jacobs?

Cindy Jacobs is 62, he's been the President of Achieve Life Sciences since 2020. There are 8 older and 7 younger executives at Achieve Life Sciences. The oldest executive at Achieve Life Sciences Inc. is Donald Joseph, 66, who is the Independent Director.

What's Cindy Jacobs's mailing address?

Cindy's mailing address filed with the SEC is 22722 29TH DR SE, SUITE 100, BOTHELL, WA, 98021.

Insiders trading at Achieve Life Sciences

Over the last 7 years, insiders at Achieve Life Sciences have traded over $972,224 worth of Achieve Life Sciences stock and bought 70,500 units worth $224,475 . The most active insiders traders include Capital, Llc Armistice Capi..., Vaughn B Himes, and Jay M Moyes. On average, Achieve Life Sciences executives and independent directors trade stock every 65 days with the average trade being worth of $63,759. The most recent stock trade was executed by Jerry Wan on 19 April 2024, trading 5,625 units of ACHV stock currently worth $24,075.



What does Achieve Life Sciences do?

achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.



Complete history of Cindy Jacobs stock trades at Achieve Life Sciences

Insider
Trans.
Transaction
Total value
Cindy Jacobs
President and CMO
Option $73,288
19 Apr 2024
Cindy Jacobs
President and CMO
Option $20,825
28 Apr 2023
Cindy Jacobs
President and CMO
Option $130,813
21 Apr 2023
Cindy Jacobs
President and CMO
Option $17,375
28 Apr 2022
Cindy Jacobs
President and CMO
Option $464
17 Aug 2021
Cindy Jacobs
President and CMO
Option $623
18 Aug 2020
Cindy Jacobs
President and CMO
Option $2,603
13 Aug 2019
Cindy Jacobs
President and CMO
Option $60
15 Jan 2019
Cindy Jacobs
President and CMO
Option $4,532
13 Aug 2018


Achieve Life Sciences executives and stock owners

Achieve Life Sciences executives and other stock owners filed with the SEC include: